Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION
December 12 2024 - 8:07AM
UK Regulatory
Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION
Christoph Baldegger, primary insider and member of the Board of
Directors in Hofseth BioCare ASA ("HBC") has today purchased
700,000 shares in HBC at an average price of NOK 1.202837 per
share.
As a result of the transaction, Mr. Baldegger holds 1,500,000
shares personally and 1,747,853 shares indirectly through the
Bonafide fund, in HBC equal to approximately 0.82 % of the total
outstanding A-shares with voting rights.
Please see the attached notification form for further
information.
Contact:
Jon Olav Ødegård, CEO of Hofseth BioCare ASA
Phone: +47 936 32 966
E-mail: joo@hofsethbiocare.no
This information is subject to the disclosure requirements in
the Market Abuse Regulation EU 596/2014 article 19 number 3 and the
Norwegian Securities Trading Act section 5-12.
- PDMR notification form - Christoph Baldegger
Hofseth Biocare Asa (LSE:0Q6H)
Historical Stock Chart
From Nov 2024 to Dec 2024
Hofseth Biocare Asa (LSE:0Q6H)
Historical Stock Chart
From Dec 2023 to Dec 2024